HER2 Status by Standardized Immunohistochemistry and Silver-Enhanced In Situ Hybridization in Korean Breast Cancer
about
Positive expression of insulin-like growth factor-1 receptor is associated with a positive hormone receptor status and a favorable prognosis in breast cancerWSG ADAPT - adjuvant dynamic marker-adjusted personalized therapy trial optimizing risk assessment and therapy response prediction in early breast cancer: study protocol for a prospective, multi-center, controlled, non-blinded, randomized, investigaExpression of matrix metalloproteinases and their inhibitors in different immunohistochemical-based molecular subtypes of breast cancerHER2 assessment by silver in situ hybridization: where are we now?Comparative analysis of the EGFR, HER2, c-MYC, and MET variations in colorectal cancer determined by three different measures: gene copy number gain, amplification status and the 2013 ASCO/CAP guideline criterion for HER2 testing of breast cancer.
P2860
HER2 Status by Standardized Immunohistochemistry and Silver-Enhanced In Situ Hybridization in Korean Breast Cancer
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
HER2 Status by Standardized Im ...... zation in Korean Breast Cancer
@ast
HER2 Status by Standardized Im ...... zation in Korean Breast Cancer
@en
type
label
HER2 Status by Standardized Im ...... zation in Korean Breast Cancer
@ast
HER2 Status by Standardized Im ...... zation in Korean Breast Cancer
@en
prefLabel
HER2 Status by Standardized Im ...... zation in Korean Breast Cancer
@ast
HER2 Status by Standardized Im ...... zation in Korean Breast Cancer
@en
P2093
P2860
P1476
HER2 Status by Standardized Im ...... zation in Korean Breast Cancer
@en
P2093
Breast Pathology Study Group of Korean Society of Pathologists
Dong Wha Lee
Eun Yoon Cho
Gyungyub Gong
Ji Shin Lee
Kwang-Sun Suh
Woo Hee Jung
Young Kyung Bae
P2860
P304
P356
10.4048/JBC.2012.15.4.381
P577
2012-12-31T00:00:00Z